tiprankstipranks
Advertisement
Advertisement
Jyong Biotech Reports Higher Assets but Deeper Shareholders’ Deficit in June 2025 Unaudited Results
PremiumCompany AnnouncementsJyong Biotech Reports Higher Assets but Deeper Shareholders’ Deficit in June 2025 Unaudited Results
5M ago
Jyong Biotech ‘not aware’ of any material information amid share price movement
Premium
The Fly
Jyong Biotech ‘not aware’ of any material information amid share price movement
6M ago
Jyong Biotech Ltd trading resumes
Premium
The Fly
Jyong Biotech Ltd trading resumes
6M ago
Jyong Biotech Ltd trading halted, volatility trading pause
PremiumThe FlyJyong Biotech Ltd trading halted, volatility trading pause
9M ago
Jyong Biotech Ltd trading resumes
Premium
The Fly
Jyong Biotech Ltd trading resumes
9M ago
Jyong Biotech completes patient enrollment in Phase II trial of MCS-8
Premium
The Fly
Jyong Biotech completes patient enrollment in Phase II trial of MCS-8
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100